Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : APPI - Advanced Plant Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Terry D. who wrote (873)	4/27/1999 10:18:00 AM
From: Tazman	Read Replies (1) \| Respond to of 1263

NEW YORK, April 27 /PRNewswire/ -- Advanced Plant Pharmaceuticals, Inc. (OTC Bulletin Board: APPI) announced today they have signed an agreement in principle with HealthSpan, Inc. (OTC Bulletin Board: HSPN) to jointly produce, market, and sell whole plant nutriceutical products on an exclusive basis for North America. HealthSpan will have the exclusive right to market, sell, and distribute to all markets in North America, to include the rapidly growing Internet marketing and sales arena, for any and all products developed by APPI on a first refusal basis. APPI will be responsible for all product development, formulation, clinicals, patents, processing and manufacturing. HealthSpan formulates, manufactures, markets, sells, and distributes quality products into the rapidly expanding nutriceutical food, vitamin and dietary aids marketplace. Nutriceuticals (nutritional pharmaceuticals) are foods, vitamins, and other dietary supplements that have proven therapeutic health benefits. HealthSpan's senior management team has been responsible for the success of dozens of products and brands for Fortune 500 companies over the past twenty years. Management's experience with retailers, mass merchandisers and catalogue fulfillment operators should lead to successes for the Company's current and future products and brands. "We are extremely pleased and proud to be working together with HealthSpan to ensure that our advanced whole plant nutritional supplements are obtainable on a national level," said Barry Clare, Chief Operating Officer for APPI. "We are very confident in HealthSpan's ability to market and build a brand name." David Lieberman, CEO for APPI further stated, "The agreement strengthens the interests of both companies. APPI will now be able to expand their research and clinical trials and provide a rapid development path in order to bring the Company's current and new products to market. All such products will continue to use the 'whole plant' standardization process under patent review. This process maximizes the yield from the various herbals sources." For further information, contact Barry Clare of Advanced Plant Pharmaceuticals at 212-402-7878 or visit APPI's web site at advancedplantpharm.com. APPI develops innovative plant formulations and technology for clinical application. APPI has a patent pending Whole Plant Pharmaceutical Grade Process which converts a whole plant into a "Fully Standardized" pharmaceutical grade product. APPI nutritional supplements offer the human body more ingredients to cure and heal because they are processed without using extraction methods which castrates the chemical formations of the plants in use. APPI currently produces a patented "Fully Standardized" pharmaceutical grade product, Lo-Chol(TM), which helps lower total cholesterol and triglycerides, but also increases HDL (good cholesterol) and balances the proportion of HDL to LDL (bad cholesterol). APPI received the first IND (investigational new drug) from the FDA for their whole plant pharmaceutical, Abavca(TM), which has clinically demonstrated potential as an immunomodulator in the treatment of patients with HIV, the virus that causes AIDS, as well as CFS (Chronic Fatigue Syndrome). APPI also produces a whole plant "All Natural" garlic (no chemicals added, preserved in nature's original chemical formation). APPI's garlic is "Fully Standardized", which means its potency levels and ingredient amounts are consistently the same. APPI is in the process of finalizing its "Fully Standardized" St. John's Wort, Echinacea, Ginkgo Biloba, Ginseng and other leading nutriceuticals. This press release contains forward-looking statements. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. SOURCE Advanced Plant Pharmaceuticals, Inc. /CONTACT: Barry Clare of Advanced Plant Pharmaceuticals, 212-402-7878/ /Web site: advancedplantpharm.com